BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

413 related articles for article (PubMed ID: 22394638)

  • 1. [Characteristics of γδ T cell subsets induced from peripheral blood mononuclear cells of HIV/AIDS patients in vitro].
    Chen WW; Wu XL; Nie WM; Xie YX; Wang L; Zhao M
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2012 Mar; 28(3):285-7. PubMed ID: 22394638
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The comparison between HIV-infected patients' Vdelta2 T cells expansion efficiencies by zoledronic acid and gammadelta TCR monoclonal antibody in vitro].
    Xu W; Wu XL; Xie YX; Yang JL; Nie WM; Zhao M; Chen WW
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2012 Dec; 26(6):442-5. PubMed ID: 23627025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toll-like receptor expression and function in subsets of human gammadelta T lymphocytes.
    Pietschmann K; Beetz S; Welte S; Martens I; Gruen J; Oberg HH; Wesch D; Kabelitz D
    Scand J Immunol; 2009 Sep; 70(3):245-55. PubMed ID: 19703014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune response of human propagated gammadelta-T-cells to neuroblastoma recommend the Vdelta1+ subset for gammadelta-T-cell-based immunotherapy.
    Schilbach K; Frommer K; Meier S; Handgretinger R; Eyrich M
    J Immunother; 2008; 31(9):896-905. PubMed ID: 18832998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distinct gene expression in human Vdelta1 and Vdelta2 gammadelta T cells following non-TCR agonist stimulation.
    Kress E; Hedges JF; Jutila MA
    Mol Immunol; 2006 May; 43(12):2002-11. PubMed ID: 16423401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phenotypic and functional heterogeneity of peripheral γδ T cells in pulmonary TB and HIV patients in Addis Ababa, Ethiopia.
    Negash M; Tsegaye A; Wassie L; Howe R
    BMC Infect Dis; 2018 Sep; 18(1):464. PubMed ID: 30219039
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NKG2C is a major triggering receptor involved in the V[delta]1 T cell-mediated cytotoxicity against HIV-infected CD4 T cells.
    Fausther-Bovendo H; Wauquier N; Cherfils-Vicini J; Cremer I; Debré P; Vieillard V
    AIDS; 2008 Jan; 22(2):217-26. PubMed ID: 18097224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Depletion of pro-inflammatory CD161(+) double negative (CD3(+)CD4(-)CD8(-)) T cells in AIDS patients is ameliorated by expansion of the γδ T cell population.
    Singleterry WL; Henderson H; Cruse JM
    Exp Mol Pathol; 2012 Feb; 92(1):155-9. PubMed ID: 22100877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Analysis of the numbers and subsets of MTB-HAg specific TNF-α
    Tang J; Chen C; Zha C; Wang Z; Zhang C; Zeng L; Li B
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Nov; 32(11):1527-1531. PubMed ID: 27774949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GammadeltaT cells in juvenile idiopathic arthritis: higher percentages of synovial Vdelta1+ and Vgamma9+ T cell subsets are associated with milder disease.
    Berkun Y; Bendersky A; Gerstein M; Goldstein I; Padeh S; Bank I
    J Rheumatol; 2011 Jun; 38(6):1123-9. PubMed ID: 21406498
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vδ1 Effector and Vδ2 γδ T-Cell Subsets Shift in Frequency and Are Linked to Plasma Inflammatory Markers During Antiretroviral Therapy-Suppressed HIV Infection.
    Pihl RMF; Smith-Mahoney EL; Olson A; Yuen RR; Asundi A; Lin N; Belkina AC; Snyder-Cappione JE
    J Infect Dis; 2024 May; 229(5):1317-1327. PubMed ID: 38390982
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence for B cell-mediated activation of V delta 1+ T lymphocytes during progression of HIV infection.
    Hyjek EM; Bartkowiak J; Drozdz R; Wasik TJ; Jasinski M; Kaneko Y; Lischner HW; Kozbor D
    J Immunol; 1997 Jan; 158(1):464-74. PubMed ID: 8977224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vdelta1 and Vdelta2 gammadelta T cells express distinct surface markers and might be developmentally distinct lineages.
    De Rosa SC; Mitra DK; Watanabe N; Herzenberg LA; Herzenberg LA; Roederer M
    J Leukoc Biol; 2001 Oct; 70(4):518-26. PubMed ID: 11590187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human Vδ1 γδ T cells expanded from peripheral blood exhibit specific cytotoxicity against B-cell chronic lymphocytic leukemia-derived cells.
    Siegers GM; Dhamko H; Wang XH; Mathieson AM; Kosaka Y; Felizardo TC; Medin JA; Tohda S; Schueler J; Fisch P; Keating A
    Cytotherapy; 2011 Jul; 13(6):753-64. PubMed ID: 21314241
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human Vdelta1 gamma-delta T cells exert potent specific cytotoxicity against primary multiple myeloma cells.
    Knight A; Mackinnon S; Lowdell MW
    Cytotherapy; 2012 Oct; 14(9):1110-8. PubMed ID: 22800570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CDR3-independent expansion of Vδ1 T lymphocytes in acquired chronic pure red cell aplasia.
    Michishita Y; Hirokawa M; Fujishima N; Abe Y; Fujishima M; Guo YM; Ubukawa K; Liu J; Yoshioka T; Kameoka Y; Saitoh H; Tagawa H; Takahashi N; Sawada K
    Immunol Lett; 2013 Feb; 150(1-2):23-9. PubMed ID: 23274961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective activation of TCR-gammadelta+ cells in endemic Burkitt's lymphoma.
    Futagbi G; Welbeck JE; Tetteh JK; Hviid L; Akanmori BD
    Malar J; 2007 May; 6():69. PubMed ID: 17521425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term use of interferon-β in multiple sclerosis increases Vδ1
    Maimaitijiang G; Watanabe M; Shinoda K; Isobe N; Nakamura Y; Masaki K; Matsushita T; Yoshikai Y; Kira JI
    J Neuroinflammation; 2019 Sep; 16(1):179. PubMed ID: 31519178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of γδ T cell subsets in organ transplantation.
    Puig-Pey I; Bohne F; Benítez C; López M; Martínez-Llordella M; Oppenheimer F; Lozano JJ; González-Abraldes J; Tisone G; Rimola A; Sánchez-Fueyo A
    Transpl Int; 2010 Oct; 23(10):1045-55. PubMed ID: 20477999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lymphocyctes Tgammadelta in clinically normal skin and peripheral blood of patients with systemic lupus erythematosus and their correlation with disease activity.
    Robak E; Niewiadomska H; Robak T; Bartkowiak J; Błoński JZ; Woźniacka A; Pomorski L; Sysa-Jedrezejowska A
    Mediators Inflamm; 2001 Aug; 10(4):179-89. PubMed ID: 11577994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.